Comparison of stage-specific outcome of breast cancer based on 5th and 6th AJCC staging system

Journal of Surgical Oncology

Volumn 93, Issue 3, 2006, Pages 221-227

  Kim, Seung Il ^a   Park, Byeong Woo ^a   Lee, Kyong Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Breast cancer; Nodal involvement; Staging system; Survival

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; CANCER STAGING; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RELAPSE FREE SURVIVAL; REVIEW; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; HUMANS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33644931606     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20513     Document Type: Review

References (17)

1. Singletary SE, Allred C, Ashley P, et al.: Revision of the American Joint Committee on Cancer Staging System for breast cancer. J Clin Oncol 2002;20:3628-3636.
2. Gusterson BA: The new, TNM classification and micrometastasis. Breast 2003;12:387-390.
3. Fisher ER, Costantino J, Fisher B, et al.: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4): Discriminants for 15-Year survival. Cancer 1993;71:2141-2150.
4. Nemoto T, Vana J, Bedwani RN, et al.: Management and survival of female breast cancer: Result of a national survey by the American College of Surgeons. Cancer 1980;45:2917-2924.
5. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
6. Fisher B, Bauer M, Wickerham L, et al.: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: An NSABP update. Cancer 1983;52:1551-1557.
7. Barth RJ, Danforth DN, Venzon DJ, et al.: Level of axillary involvement by lymph-node metastases from breast cancer is not an independent predictor of survival. Arch Surg 1991;126:574-577.
8. Greene FL, Page DL, Fleming ID, et al.: AJCC cancer staging manual, 6th edition. New York: Springer, 2002.
9. Dent DM: Axillary lymphadenectomy for breast cancer. Paradigm shifts and pragmatic surgeons. Arch Surg 1996;131:1125-1127.
10. Yarbro JW, Page DL, Fielding LP, et al.: American Joint Committee on Cancer prognostic factors consensus conference. Cancer 1999;86:2436-2446.
11. Hermanek P Sobin LH, Wittekind C: How to improve the TNM staging system. Cancer 1999;86:2189-2191.
12. Singletary SE, Greene FL: Revision of breast cancer staging: The 6th edition of the TNM classification. Semin Surg Oncol 2003;21:53-59.
13. Woodward WA, Strom EA, Tucker SL, et al.: Changes in the 2003 American Joint Committee on Cancer Staging for breast cancer dramatically affected stage-specific survival. J Clin Oncol 2003;21:3244-3248.
14. Jones SE, Moon TE, Bonadonna G, et al.: Comparison of different trials of adjuvant chemotherapy in stage II breast cancer using a natural history data base. Am J Clin Oncol 1987;10:387-395.
15. Crump M, Goss PE, Prince M, et al.: Outcome of extensive evaluation before adjuvant therapy in women with breast cancer and 10 or more positive axillary lymph nodes. J Clin Oncol 1996;14:66-69.
16. Lee RJ, Ham B, Vetto J, et al.: Breast cancer severity score is an innovative system for prognosis. Am J Surg 2003;186:404-408.
17. Donegan WL: Prognostic factors. Stage and receptor status in breast cancer. Cancer 1992;70:1755-1764.